दवाओं की अंतःक्रिया
Armodafinil + Elacestrant
गंभीरता: गंभीर
Armodafinil and Elacestrant: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Elacestrant is mainly cleared by CYP3A4, and induction by armodafinil may lower its plasma levels and compromise anticancer efficacy. Labeling advises avoiding strong and moderate CYP3A inducers.
इस इंटरैक्शन का सरल भाषा में अर्थ
Armodafinil and Elacestrant can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Armodafinil belongs to Central Nervous System; Elacestrant belongs to Oncology.
ऐसा क्यों होता है
Armodafinil induces CYP3A4, increasing the metabolic clearance of elacestrant.
क्या करें
Avoid concomitant use where possible and choose a non-inducing wakefulness alternative. If combined, monitor oncologic response closely.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Armodafinil और Elacestrant की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Armodafinil के अन्य इंटरैक्शन
Elacestrant के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Armodafinil with Elacestrant?
MediHelp rates the interaction as major. Armodafinil and Elacestrant can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Elacestrant is mainly cleared by CYP3A4, and induction by armodafinil may lower its plasma levels and compromise anticancer efficacy. Labeling advises avoiding strong and moderate CYP3A inducers.
How serious is the interaction between Armodafinil and Elacestrant?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concomitant use where possible and choose a non-inducing wakefulness alternative. If combined, monitor oncologic response closely.
What other medicines interact with Armodafinil?
MediHelp also lists interactions of Armodafinil with, for example, Avapritinib, Cyclosporine, Elbasvir / grazoprevir. The full list is on the Armodafinil page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
